American Society of Gene and Cell Therapy 24th Annual Meeting

  • Маргарита Владимировна Романенко (Участник)

Деятельность: Участие в мероприятии или организация мероприятия.Участие в конференции, заседании рабочей группы, ...


Oral session
Novel oncolytic Ad6 vectors for cancer therapy
Margarita Romanenko, PhD, University of Minnesota, Minneapolis, MN, discusses potential future applications of oncolytic adenoviral vectors. Currently approved vector-based COVID-19 vaccines utilize adenoviral vector technology of varying serotypes, including adenovirus serotype 6 (Ad6). Dr Romanenko anticipates that therapeutics based on a range of adenovirus serotypes will be developed in the future and highlights this technology’s promise given the oncolytic potential and capacity for gene insertion associated with oncolytic adenoviral vectors. This interview took place during the American Society for Cell & Gene Therapy 24th Annual Meeting 2021.
Период13 мая 2021
Тип мероприятияКонференция
МестонахождениеСоединенные Штаты АмерикиПоказать на карте
Степень признанияМеждународная